Home/Filings/4/0001192482-19-000146
4//SEC Filing

Early James 4

Accession 0001192482-19-000146

CIK 0001054102other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:56 PM ET

Size

7.5 KB

Accession

0001192482-19-000146

Insider Transaction Report

Form 4
Period: 2019-03-13
Early James
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2019-03-13+26,34043,340 total
  • Award

    Stock Option (right to buy)

    2019-03-13+105,360105,360 total
    Exercise: $0.98Exp: 2029-03-13Common Stock (105,360 underlying)
Footnotes (3)
  • [F1]The restricted stock units vest annually, in equal installments, over a three-year period, commencing on March 13, 2020.
  • [F2]Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
  • [F3]The stock options vest and become exercisable over a three-year period, in equal installments, commencing on March 13, 2020, subject to the reporting person's continued service with the Issuer.

Issuer

Interpace Diagnostics Group, Inc.

CIK 0001054102

Entity typeother

Related Parties

1
  • filerCIK 0001687977

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:56 PM ET
Size
7.5 KB